Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript May 14, 2026

Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05.

Operator: Good morning, and welcome to the Lucid Diagnostics First Quarter 2026 Business Update Conference Call. Please note that this event is being recorded. I would now like to turn the conference over to Matt Reilly, Lucid Diagnostics Vice President of Investor Relations. Please go ahead.

Matthew...